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Abstract
Introduction
Neuromuscular weakness resulting in severe functional impairment is common in critical
care survivors. This study aimed to evaluate effects of an early progressive rehabilitation
intervention in mechanically ventilated adults at risk.
Methods
This was a parallel, two-arm, assessor-blinded, randomised controlled trial with 6-months
follow-up that was conducted in a mixed ICU of an academic centre in Switzerland. Previ-
ously independent, mechanically ventilated, critically ill adults with expected critical care
stay�72 hours (n = 115) were randomised to a control group receiving standard physiother-
apy including early mobilisation or to an experimental group with early endurance and resis-
tance training combined with mobilisation. Primary endpoints were functional capacity (6-
Minute Walk Distance) and functional independence (Functional Independence Measure) at
hospital discharge. Secondary endpoints including muscle strength were assessed at criti-
cal care discharge. Safety was monitored closely by standard monitoring and predefined
adverse events.
Results
Physiotherapy started within 48 hours of critical care admission while 97% of participants
were still ventilated and 68% on inotropes. Compared to the control group (n = 57), the
experimental group (n = 58) received significantly more physiotherapy (sessions: 407 vs
377, p<0.001; time/session: 25min vs 18min, p<0.001) and had less days with sedation
(p<0.001). Adverse events were rare (0.6%) and without consequences. There were no sig-
nificant between-group differences in 6-Minute Walk Distance (experimental 123m (IQR
25–280) vs control 100m (IQR 0–300); p = 0.542) or functional independence (98 (IQR 66–
119) vs 98 (IQR 18–115); p = 0.308). Likewise, no differences were found for the secondary
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outcomes, except a trend towards improved mental health in the experimental group after 6
months (84 (IQR 68–88) vs 70 (IQR 64–76); p = 0.023).
Conclusions
Early endurance and resistance training in mechanically ventilated, intensive care patients
does not improve functional capacity or independence at hospital discharge compared to
early standard physiotherapy but may improve mental health 6-months after critical care
discharge.
Trial registration
German Clinical Trials Register (DRKS): DRKS00004347, registered on 10 September
2012.
Introduction
Intensive care unit acquired weakness (ICUAW) is common in critical illness survivors. It
increases health-care costs and impairs quality of life [1]. ICUAW mainly affects skeletal mus-
cles (critical illness myopathy) and peripheral nerves (critical illness polyneuropathy) [2], but
its causes are poorly understood [3]. Symptoms of ICUAW develop within the first week of
critical illness [4]. Its risk factors include sepsis, multiple organ failure, mechanical ventilation
(MV), immobilisation and hyperglycaemia [3]. ICUAW is associated with worse short- and
long-term outcomes, including weaning failure [5], prolonged ICU and hospital stays [6],
increased mortality [7], and poor functional status with persistent disability in activities of
daily living [1, 8–10].
Early rehabilitation and mobilisation may help to reduce the functional disabilities of
ICUAW patients. Some promising short-term outcomes have been reported [11, 12], but
long-term benefits from randomised controlled trials are warranted [13–15]. Delayed inter-
vention onset (�1 week) [12, 13, 15], low ICUAW-risk in targeted population [11] or unspe-
cific exercise delivery [11, 14] may have contributed to the inconclusive results. Despite these
limitations in evidence, many ICUs, including ours, have adopted early mobilisation, also as a
consequence of using less sedation. We aimed to investigate a specific rehabilitation interven-
tion that could be implemented early in a highly ill population with a high ICUAW risk.
Resistance training can restore strength after bed-rest in older adults [16]. Combined
endurance and resistance training (ERT) enhances exercise capacity and health-related quality
of life in patients with chronic obstructive pulmonary disease [17] and prevents cardiovascular
and skeletal muscle deconditioning during bedrest [18]. Whether early ERT is feasible, safe
and beneficial in critically ill patients of whom many are still mechanically ventilated and
treated with opioids or recovering from sedation is unclear. We hypothesised that early ERT
combined with mobilisation in the ICU is feasible and might improve function at hospital dis-
charge. This randomised controlled trial compared the effects and safety of early ERT com-
bined with early mobilisation to standard care including early mobilisation in critically ill,
mechanically ventilated adults for a period of up to 6-months after hospital discharge.
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Methods
Design and setting
This single-centre, parallel, two-arm, assessor-blinded randomised controlled trial with
6-months follow-up was conducted in the tertiary, mixed ICU of the Department of Intensive
Care Medicine at the Inselspital, Bern University Hospital, Switzerland. The trial was approved
by the local Ethics Committee and prospectively registered in the German Clinical Trials Reg-
ister (DRKS00004347) on September 10, 2012. It adhered to Good Clinical Practice Guidelines
and the CONSORT statement (S1 Checklist). The study protocol has previously been pub-
lished [19].
Participants
Adults (�18 years) expected to stay on MV for at least 72 hours and who had been indepen-
dent before the onset of critical illness were eligible for participation. Independence was
defined as living without assistance and qualitatively determined by the patient’s family or
medical-health records. Exclusion criteria were previous muscle weakness, contraindications
to cycling, enrolment in another intervention study, palliative care, admission diagnosis that
excluded the possibility of walking at hospital discharge, and patients who did not understand
German or French [19].
Procedures
Patients were screened daily by a research nurse and a specialist physiotherapist who evaluated
cycling eligibility. The expected MV duration was judged by the responsible physician. Subse-
quently and before study inclusion, an independent medical doctor confirmed eligibility crite-
ria. Physicians and physiotherapists were unaware of the randomisation sequence. A deferred
consent was obtained from the next of kin within 72 hours after randomisation and a written
informed consent from each patient as early as possible. Unrestricted, computer-generated
randomisation (https://www.random.org/lists/) was performed by a study nurse partly
involved in screening eligible candidates. Participants were allocated at a 1:1 ratio to either
group using sequentially numbered opaque sealed envelopes to ensure allocation concealment
[20]. Coded data was managed with REDcap [21].
Blinding the responsible ICU staff was impossible, but the physiotherapy assessors were
blinded for group allocation and distinct from the therapists providing the intervention. How-
ever, logistical reasons prevented therapist separation between the two treatment groups. Dis-
charge decisions were made by the primary care team without the involvement of
physiotherapists.
Interventions
Both groups received standard ICU care with protocol-guided sedation, weaning [22] and
nutrition [23]. In cases of ICU readmissions, treatment according to initial group allocation
was continued.
Standard care (control group). Patients in the control group received European standard
physiotherapy [24] including early mobilisation, respiratory therapy and passive or active exer-
cises. These were physiotherapy-initiated and individually tailored, but subject to a medical
prescription. Treatments took place once daily on weekdays and on weekends if the responsi-
ble therapists deemed an interruption of therapy to be harmful to patient’s previous progress
(e.g. intensive rehabilitation and weaning period or retained airway secretion in extubated
patients).
Early ICU training—RCT
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Study intervention (experimental group). In patients in the experimental group an
early, progressive ERT programme combined with early mobilisation (S1 Fig) was initiated
and each component implemented as intensive as possible and tolerated in individual patients.
To this end, sedation was reduced if medically permitted prior to physiotherapy [19]. Physio-
therapists were encouraged to split therapy into two or more sessions to prevent overexertion.
Therapy visits occurred from Monday to Friday up to a maximum of three sessions per day
and on weekends if deemed helpful to patient’s progress.
Endurance training was conducted with a motor-assisted bed-cycle (MOTOmed letto2, Reck-
Technik, Betzenweiler, Germany) that allows passive, motor-assisted or active cycling in bed.
Patients were comfortably positioned in a supine position with an individual head-of-bed elevation
to permit optimal leg movement. Maximal training intensity for unresponsive patients was 20 min-
utes with a pedalling rate of 20 cycles/min [12]. During each session, patients were prompted ver-
bally and with the MOTOmed ServoCycle feature to actively participate. When patients were able
to cycle with motor-assistance for 20 minutes, assistance was gradually decreased. Only then was
training duration raised to 30 minutes. Subsequently, resistance and then duration were increased
with a defined maximum of 60 minutes with full resistance (S1 Table).
Resistance training included standardised exercises for both upper and lower limbs using
weights or manually administered resistance from the therapist. The targeted training intensity
was 8–12 repetitions with 2–5 sets (2min rest) on 50–70% of the estimated one-repetition max-
imum. Once the exercises were performed properly, participants were given an illustrated
handout for further training with family members or nurses. In patients unable to perform
resistance exercises because of lack of strength or comprehension, physiotherapists used pas-
sive movement or tactile facilitation to excite movement.
Early mobilisation was started with in-bed exercises and, if no medical contraindications
were present, continued progressively from sitting on the bedside to sitting in a chair to stand-
ing and, finally, to walking. The overall aim was patients’ active participation in functional
activities of daily living in order to promote early independence.
Usual physiotherapy was provided for patients after ICU discharge once to twice a day. Sessions
commonly involved functional exercises, cycling, walking, strengthening and breathing techniques.
Outcomes
The two primary outcomes were functional capacity (6-Minute Walking Distance (6MWD)
[25]) and the ability to perform activities of daily living (Functional Independence Measure
(FIM) [26]) at hospital discharge.
Secondary outcomes were FIM and muscle strength at ICU discharge. Muscle strength was
assessed if patients could follow at least 3 out of 5 standardised questions [27]. Assessments
included the Medical Research Council (MRC) sum-score for ICUAW diagnosis [2], handgrip
strength using the JAMAR dynamometer (Sammons Preston Rolyan, Bolingbrook, IL, USA)
[28] and quadriceps muscle strength measured with a handheld dynamometer (Microfet 2,
Biometrics, Almere, Netherlands) [29]. Additionally, limitations in range-of-motion were
recorded for shoulder flexion, elbow flexion and extension, fist closure, hip flexion, knee flex-
ion and extension and foot dorsiflexion [30]. To assess functional mobility the Timed ‘Up &
Go’ was performed at hospital discharge [31]. Further endpoints were time on MV, ICU and
hospital length of stay along with achieved ICU mobility. Quality of life was determined with
the Short Form 36 (SF-36) six months after hospital discharge. The SF-36 is a valid and reliable
measurement to assess long-term physical and mental health in ICU survivors [32].
To judge training intensity and stability, physiological trends and individually-set limits
instead of strict target numbers were used to account for each patient’s condition and
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variability. Safety was closely monitored using standard ICU monitoring and indirect calorim-
etry for 30min before, during and 15min after physiotherapy. Physiological data was recorded
in a patient data management system that stored 2-minute median values to remove artefacts.
Prospectively defined adverse events (AE) included new hemodynamically relevant arrhyth-
mias or otherwise unstable hemodynamics, oxygenation desaturation under 85%, a fall or
other injury and any accidental removal of a tube, catheter or similar device. Per definition,
AEs occurred during or up to 15min after physiotherapy and persisted despite an intervention
or therapy interruption. Other known complications of bedrest, e.g. atelectasis or pressure
ulcers, were recorded along with any serious AE which included death, a life-threatening
injury or any event that caused an extension of hospital stay.
Statistical analysis
Sample size determination was based on the 6MWD to show a difference of 54m [33] and a
mean walking distance of 301m (SD 81) [34]. A statistical power of 80% and an α-level of 0.05
required a sample size of totally 72 patients (36 per group). This was further adjusted by 28
patients, due to two primary outcomes that were expected to highly correlate. Lastly, the over-
all sample size was increased by 15% to 115 participants because of expected attrition, includ-
ing mortality. It was decided a priori that refusals to participate (presumed consent not
obtained within 72h of randomisation) were compensated for and were not to be included in
the intention-to-treat analysis. The number of these additional participants was determined
after the inclusion of 115 patients. As a consequence, 130 patients were randomised until the
number of 115 participants with presumed consent was reached.
Analysis was by intention-to-treat and per protocol using SPSS (IBM SPSS Statistics Version
Premium GradPack 24), and R (Version 3.4.4). In the per protocol analysis, patients who died
were allocated the lowest possible outcome for both primary outcomes. The intention-to-treat
analysis was conducted with multiple imputation using a linear regression model that imputed all
missing values (including death). Sensitivity analyses for both primary outcomes were conducted
to test the robustness of the main analysis. Secondary outcomes were analysed as measured.
Between group comparisons for normally distributed data included Student’s t-tests and for non-
normally distributed data Mann-Whitney-U tests. Dichotomous data was analysed with Fisher’s
exact test, repetitive data with repeated measures analysis of variance (ANOVA) and correlations
with Spearman correlation coefficients. Continuous data are presented as means with standard
deviation (SD) or median with interquartile range (IQR) dependent upon their distribution. Cate-
gorical data are given as numbers with percentages. Treatment effects are reported with 95% Con-
fidence intervals (95% CI) as mean differences (MD) for normally distributed data, as estimator
for difference in location for non-normal data (Wilcoxon-Mann-Whitney test implemented in R
package “coin”), and as incidence rate ratios (IRR) or risk differences (RD) for percentages. IRRs
and RDs were calculated with R using Exact Poisson and Proportion test, respectively. Effect sizes
were calculated with Cohen’s d for normally distributed data and with Cohen’s r for Wilcoxon-
Mann-Whitney test statistic in case of non-normal data (using appropriate z value as in [35]). The
level of significance was set at p< 0.05. A preliminary safety analysis has been conducted after the
enrolment of 35 participants [36].
Results
Study participants
From October 8, 2012 to April 5, 2016, we randomised 130 patients for whom 15 (12%)
patient’s proxy declined initial study participation. These were excluded from all further analy-
ses, as requested by the Ethics Committee. Consequently, 115 patients (experimental n = 58,
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control n = 57) were included in the intention-to-treat analysis. (Fig 1). Baseline demographics
and clinical characteristics were similar between groups (Table 1).
Primary outcomes
No significant differences were found between groups in the intention-to-treat and the per
protocol analysis (Table 2). There was a high positive correlation (p<0.001, r = 0.833) between
the two primary outcomes. Results were robust in sensitivity analyses (S2 Table).
Secondary outcomes
There were no significant differences between groups at ICU and hospital discharge (Table 3).
The incidence of ICUAW at ICU discharge, determined by MRC sum-score in cooperative
patients, was 58% (23/40) in the experimental and 61% (26/43) in the control group (n = 83;
p = 0.826). Limitations in range-of-motion were observed in 22 (38%) patients of the experi-
mental and in 16 (28%) of the control group (n = 115; p = 0.323) with a median of 2 (IQR 0–3)
affected joints per patient. No joint was particularly vulnerable for contracture. There were no
significant differences for ICU (p = 0.694) and hospital discharge destinations (p = 0.555)
between groups. The most frequent discharge destinations for survivors were rehabilitation
(40%; experimental n = 25, control n = 21), local hospital (26.1%; experimental n = 17, control
n = 13) and home (15.7%; experimental n = 7, control n = 11). Except for mental health
(p = 0.023), there were no significant differences in quality of life at 6-months after hospital
discharge (Table 3). Because of substantial missing data for the SF-36, characteristics for
patients with and without the 6-month follow-up were compared. There were no significant
differences between patients that completed the SF-36 versus patients that did not return the
questionnaire (S3 Table).
Safety
Safety details are given in Table 4. Overall, 25 (3%) of all physiotherapy sessions had to be dis-
continued (between-groups difference p = 0.839). The most frequent reasons for therapy dis-
continuation were exceedance of individually set limits (n = 8, 32%), lack of patient
cooperation (n = 5, 20%) and fatigue (n = 3, 12%). There were 4 (0.6%) AEs, 1 (0.2%) in the
experimental group due to an oxygen desaturation while cycling and 3 (0.8%) in the control
group during mobilisation (one oxygen desaturation, two unstable haemodynamics). All AEs
resolved after therapy discontinuation and did not have further consequences. The incidence
of ICU complications did not differ between the two groups. ICU, hospital- and 6-month mor-
tality rates were similar between groups over the study period.
Patients on MV (S1 File) had a significant effect over time (30min before, during and
15min after physiotherapy) for mean arterial pressure (MAP; p<0.001, effect size η2 = 0.192),
heartrate (HR; p<0.001, η2 = 0.161) and oxygen consumption (VO2; p<0.001, η2 = 0.224), but
not for peripheral oxygen saturation (SpO2; p = 0.396, η2 = 0.017; repeated measures
ANOVA). Post-hoc paired t-test with adjusted levels of significance (p<0.017) found increases
from before to during physiotherapy for MAP (mean difference (95% CI): -1.83mmHg (-2.61
to -1.05), p<0.001), HR (-1.21beats/min (-1.76 to -0.65), p<0.001) and for VO2 (-12.22ml/min
(-16.75 to -7.69), p<0.001). Additionally, there was an increase in HR from before to after
physiotherapy (-0.83beats/min (-1.47 to -0.18), p = 0.012) and a decrease in VO2 from during
to after physiotherapy (6.27ml/min (1.45 to 11.08), p = 0.011). Likewise, predominantly spon-
taneously breathing patients (S1 File) had a significant effect over time for MAP (p = 0.046,
η2 = 0.073) and HR (p = 0.004, η2 = 0.123), but not for SpO2 (p = 0.083, η2 = 0.059). Post-hoc
paired t-test with adjusted levels of significance (p<0.017) showed an increase from before to
Early ICU training—RCT
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Fig 1. Study flow diagram (CONSORT).
https://doi.org/10.1371/journal.pone.0207428.g001
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during physiotherapy for HR (-1.85 beats/min (-3.16 to -0.53), p = 0.006). There were no sig-
nificant differences between groups for any of the vital parameters.
Study interventions
The experimental group trained on 73% of study days (349 daily physiotherapy visits, includ-
ing 407 individual sessions), whereas the control group received therapy on 65% of study days
Table 1. Baseline demographic and clinical characteristics.
Experimental group
n = 58
Control group
n = 57
Age, years, mean (SD) 65±15 63±15
Sex, female, n (%) 22 (38%) 16 (28%)
Weight, kg, mean (SD) 82±18 80±16
BMI, kg/m2, mean (SD) 28±6 27±4
APACHE II score, mean (SD) a 22±8 23±7
TISS-28 score, median (IQR) 37 (31–42) 37 (32–44)
TISS-76 score, median (IQR) 46 (39–56) 48 (41–56)
ICU days until study inclusion, mean (SD) 1.9±1.2 1.8±1.2
SOFA score, median (IQR) b 8 (6–10) 8 (7–12)
ICU diagnosis on ICU admission
Heart surgery 13 (11%) 8 (7%)
Neurology / neurosurgery 5 (4%) 4 (3%)
Other surgery 5 (4%) 9 (8%)
Gastroenterology 7 (6%) 7 (6%)
Trauma 1 (1%) 3 (3%)
Respiratory insufficiency 13 (11%) 12 (10%)
Hemodynamic insufficiency 13 (11%) 13 (11%)
Other 1 (1%) 1 (1%)
Comorbidities on ICU admission (n = 111: experimental n = 54, control n = 57)
NYHA symptoms (stage 2 to 4) 22 (41%) 26 (46%)
Dyspnoea symptoms 15 (28%) 15 (26%)
Hematologic malignancy 0 (0%) 5 (9%)
Immunosuppression 4 (7%) 12 (21%)
Liver disease 9 (17%) 6 (11%)
Chronic dialysis 0 (0%) 0 (0%)
Restricted in activities of daily living c 8 (15%) 5 (9%)
Laboratory on ICU admission
CRP, mg/l, median (IQR), n = 106 95 (49–276) 76 (30–147)
Creatinine, μmol /l, median (IQR), n = 109 97 (70–168) 111 (78–156)
Bilirubin, μmol /l, median (IQR), n = 68 15 (8–54) 18 (8–32)
Thrombocytes, 109/L, median (IQR), n = 113 117 (102–216) 108 (67–148)
Leucocytes, 109/L, median (IQR), n = 133 11 (8–16) 11 (6–16)
Haemoglobin, g/L, median (IQR), n = 115 109 (97–119) 102 (85–115)
a at ICU admission
b at study inclusion
c inability to walk for longer distances or to participate in social life
Data are presented as median (IQR), mean (SD) or n (%)
Abbreviations: NYHA = New York Heart Association, BMI = Body Mass Index, APACHE = Acute Physiology and Chronic Health Evaluation, TISS = Therapeutic
Intervention Scoring System, SOFA = Sequential Organ Failure Assessment, CRP = C-reactive protein
https://doi.org/10.1371/journal.pone.0207428.t001
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(365 visits, 377 sessions; Table 5). The main reasons for missed physiotherapy visits were week-
ends (188, 58%), day of ICU discharge (42, 13%), medical procedures (33, 10%) or cardiorespi-
ratory instability (19, 6%). Patients in the experimental group had a median of 3.5 sessions
(minimum 0, maximum 66) and patients in the control group of 3 sessions (minimum 0, max-
imum 39) (S2 File). Treatment session duration was slightly longer in the experimental group
(25min (IQR 19–27) vs control 18min (IQR 14–21); p<0.001). This was recorded from the
beginning to the end of actual therapy delivery and did not include preparation time, cleaning
materials and documentation. On average, physiotherapy started within 48 hours (n = 113;
median 1.98 days (IQR 1.41–2.86); experimental 47h (IQR32-68); control 52h (IQR 36–70);
p = 0.468) after ICU admission and within 4 hours after randomisation. At this time 97% of
participants were still ventilated (experimental 57(100%), control 52(93%); p = 0.057), 97%
sedated (experimental 55(97%), control 55(98%), p<0.999), 68% on vasoactive support (exper-
imental 42(74%), control 35(63%); p = 0.230), 19% paralysed (experimental 9(16%), control 12
(21%); p = 0.477) and 97% received opioids (experimental 55(97%), control 54(96%);
p<0.999). Patients in the experimental group were less likely to receive sedation (incidence
risk ratio (IRR) 1.66 (1.26 to 2.18, p = 0.0002) and steroids (IRR 1.18 (1.03 to 1.35), p = 0.016),
but more likely to receive vasopressors (IRR 0.77 (0.64 to 0.92), p = 0.005) compared to the
control group.
The number of each therapy intervention per group is outlined in Fig 2. Most patients were
unable to perform the planned resistance training (sessions experimental 8, control 2;
p = 0.052) with the exception of some long-stayers (S4 Table). Type of cycling included passive
(141, 76%), mixed (28, 15%) and active training modes (17, 9%). Mean cycling distance was
1183 m (±721) during an average of 15min (±5), a pedalling rate of 20r/min (±7) and a resis-
tance level of 0.2 (±0.8). Physiotherapy-initiated and overall mobilisations differed between
groups; the experimental group had more edge-of-bed mobilisations, while the control group
stood more (S2 File). However, achievement of milestones from time of randomisation to first
edge-of-bed were not different (experimental 4d (IQR 2–7), control 5d (IQR 2–7); p = 0.451)
(S2 File).
Discussion
This randomised controlled trial did not find an advantage of early ERT combined with mobi-
lisation over standard early mobilisation and rehabilitation. While participants in the experi-
mental group received more therapy and had less days with sedation, control group
Table 2. Results for the two primary outcomes per protocol and intention-to-treat analysis.
Experimental group
n = 58
Control group
n = 57
p value Effect size Group difference
(95% CI)
n value n value
Per Protocol analysis
6 Minute Walking Distance (m) 54 123 (IQR 25–280) 53 100 (IQR 0–300) p = 0.542 0.006 0.00 (-35.00 to 65.00)
FIM (18–126) 54 98 (IQR 66–119) 52 98 (IQR 18–115) p = 0.308 0.010 3.00 (-2.00 to 14.00)
Intention-to-treat analysis a
6 Minute Walking Distance (m) 58 223±133 57 246±167 p = 0.448 -0.151 -22.75 (- 81.66 to 36.16)
FIM (18–126) 58 101±22 57 99±24 p = 0.659 0.085 1.98 (-6.85 to 10.82)
a Multiple imputation from a linear regression model based on age, gender, BMI, weight, APACHE II score, TISS-28, Tiss-76, SOFA score, ICU days until
randomisation, length of stay in ICU and hospital, duration of mechanical ventilation, FIM score and MRC sum-score at ICU discharge. All missing values (including
death before hospital discharge) were imputed (6MWD: n = 33, FIM: n = 32).
https://doi.org/10.1371/journal.pone.0207428.t002
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participants had more out-of-bed mobilisations. Functional capacity and independence did
not differ between these two different exercise regimes at hospital discharge. No differences
were found in the secondary outcomes, except for a trend towards improved mental health at
6-months after hospital discharge. AEs were rare and a stepwise, individually-supervised train-
ing approach starting within 48 hours of ICU admission appears safe. ERT interventions are
feasible and highly beneficial for functional improvement in chronic obstructive pulmonary
disease [17] and we hypothesised that they may be equally feasible and effective in the critically
ill. However, the transfer of these interventions may not be as straightforward as anticipated.
Pulmonary rehabilitation is usually delivered over 8 to 12 weeks [17], while our exercise expo-
sure was limited to the time spent in ICU, when patients were recovering from critical illness,
mostly still on mechanical ventilation, receiving opioids and sedatives or at least recovering
from previously received sedatives. Since the patients in our study spent the greater part of
Table 3. Results of secondary outcomes.
Experimental group
n = 58
Control group
n = 57
p value Effect size Group difference
(95% CI)
n value n value
Hospital discharge
Timed “Up & Go” Test (s) 36 19.5 (IQR 11.5–25.0) 28 16.0 (IQR 10.3–29.0) p = 0.538 0.010 1.70 (-3.70 to 7.00)
Time on mechanical ventilation (days) 58 5.4 (IQR 3.3–12.9) 57 5.0 (IQR 3.6–11.9) p = 0.830 -0.002 -0.17 (-1.65 to 1.49)
Length of stay ICU (days) 58 6.1 (IQR 4.0–12.3) 57 6.6 (IQR 4.6–14.7) p = 0.568 -0.005 -0.44 (-2.27 to 1.20)
Length of stay hospital (days) 58 25.9 (IQR 14.3–37.2) 57 22.0 (IQR 15.0–39.2) p = 0.723 0.003 1.31 (-4.85 to 7.92)
ICU discharge
FIM (18–126) 58 28.5 (IQR 21.0–42.0) 56 28.5 (IQR 19.5–41.5) p = 0.791 0.002 0.00 (-4.00 to 5.00)
MRC sum-score
(0–60)
40 42.4±13.1 43 44.4±11.7 p = 0.461 -0.161 MD -2.02 (-7.45 to 3.41)
Handgrip strength (JAMAR) (kg) 30 20.5±12.6 40 19.6±13.6 p = 0.780 0.069 MD 0.90 (-5.47 to 7.25)
Quadriceps strength
(HDD) (kg)
28 7.7±4.0 33 8.0±3.9 p = 0.771 -0.076 MD -0.30 (-2.32 to 1.73)
6-month follow-up: SF-36
Physical functioning (0–100) 36 75.0 (IQR 45.0–85.0) 27 75.0 (IQR 50.0–85.0) p = 0.676 -0.007 -1.11 (-15.00 to 10.00)
Role physical
(0–100)
36 25.0 (IQR 0.0–62.5) 25 33.3 (IQR 25.0–50.0) p = 0.443 -0.013 0.00 (-25.00 to 0.00)
Bodily pain (0–100) 36 80.0 (IQR 51.0–100.0) 27 74 (IQR 41.0–100.0) p = 0.530 0.010 0.00 (-9.00 to 20.00)
General health
(0–100)
36 57.9±18.4 25 61.1±19.0 p = 0.513 -0.162 MD -3.20 (-12.91 to 6.52)
Vitality (0–100) 36 55.4±19.4 26 48.3±20.1 p = 0.167 0.359 MD 7.10 (-3.06 to 17.26)
Social functioning (0–100) 36 75.0 (IQR 65.3–100.0) 26 68.8 (IQR 50.0–100.0) p = 0.458 0.012 0.00 (0.00 to 25.00)
Role emotional
(0–100)
35 66.7 (IQR 33.3–100.0) 26 50.0 (IQR 0.0–100.0) p = 0.870 0.003 0.00 (0.00 to 33.33)
Mental health
(0–100)
35 84.0 (IQR 68.0–88.0) 26 70.0 (IQR 64.0–76.0) p = 0.023 0.037 12.00 (0.00 to 16.00)
Physical health
(sum-score)
34 40.8±11.1 24 42.7±10.4 p = 0.520 -0.190 MD-1.87 (-7.65 to 3.91)
Mental health
(sum-score)
34 49.4±10.3 24 45.2±11.4 p = 0.147 0.381 MD 4.23 (-1.53 to 9.99)
Data are presented as median (IQR), mean (SD) or n (%)
Abbreviations: FIM = Functional Independence Measure (worst score 18: dependent, best score 126: independent), HHD = handheld dynamometer, LOS = length of
stay, SF-36 = Short Form 36, version 2 (worst score: 0, best score: 100, sum-score: T-values where the population mean is 50 and the SD is 10; based on US-population
1990), MD = Mean Difference
https://doi.org/10.1371/journal.pone.0207428.t003
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their hospital-stay on wards or step-down units (experimental 77%, control 70%) and the
main reason for missed therapy visits were weekends (58%), extended protocol-exposure with
more resistance training might have enhanced potential group differences. The median ICU-
stay of 6 days seemed to have been too short to properly introduce resistance training, which
was defined as using weight or resistance. However, assistive exercise (experimental group:
25% of movement exercises) in the very weak patient may affect strength as well. Wright et al
[37] reported a higher but still modest percentage of sessions (33%) with this type of strength-
ening. In their study, similar to ours, sedation and patient fatigue prevented implementation
or targeted intensity. Weakness (58% with ICUAW in our study) and ongoing effects of seda-
tive agents despite significant reduction in their use in this group may both have contributed.
The main difference between our study and previous ones reporting benefits from early
mobilisation is that the control group was also mobilised early, as per our ICU standard. We
started the intervention very early in both groups, while patients were still mechanically venti-
lated and on vasoactive support, whereas most [12, 13, 15, 37, 38], but not all other interven-
tion groups [11, 39] started substantially later. Nevertheless, our control group received
physiotherapy as early as the intervention group in the study of Schweickert et al [11], and
more often than treatment groups in other trials [37, 38]. In contrast to our study, Schaller
et al [39] found that early mobilisation shortened ICU length of stay and improved functional
mobility in surgical ICU patients at hospital discharge. Contribution of treatment of control
groups to the different results cannot be evaluated due to insufficient details of care received in
Schaller’s study. Yet the case mix appears very different: our patients were sicker (mean
APACHE II 23 vs 16 in [39]) and had less surgical patients. It is therefore conceivable that the
early and intensive physiotherapy in the control group of our study explains the lack of effect
Table 4. Safety details for the control and experimental groups.
Experimental group (n = 58,
478 study days)
Control group
(n = 57, 558 study days)
p value Group difference
(95% CI)
Safety
PT discontinuation (% of total physiotherapy sessions) 12 (3%) 13 (3%) p = 0.842 IRR 0.86 (0.36 to 2.03)
Adverse event
(% per sessions)
1 (0.2%) 3 (0.8%) p = 0.357 IRR 0.31 (0.01 to 3.85)
Mortality
ICU mortality 9 (16%) 10 (18%) p = 0.770 RD -2% (-16 to 12%)
In-hospital mortality 10 (17%) 14 (25%) p = 0.334 RD -8% (-22 to 7%)
Mortality after 180 days 16 (28%) 16 (28%) p = 0.954 RD 0% (-17% to 16%)
ICU complications a
Delirium-free ICU days 256 (61%) 300 (64%) p = 0.524 IRR 0.95 (0.80 to 1.12)
Atelectasis-free ICU days 334 (93%) 402 (91%) p = 0.739 IRR 1.03 (0.88 to 1.19)
Pneumonia-free ICU days 293 (94%) 355 (92%) p = 0.782 IRR 1.02 (0.87 to 1.20)
Thrombosis-free ICU days 415 (96%) 473 (94%) p = 0.788 IRR 1.02 (0.90 to 1.17)
Decubiti-free ICU days 411 (96%) 493 (95%) p = 0.867 IRR 1.01 (0.89 to 1.16)
Contracture-free ICU days 448 (96%) 535 (96%) p>0.999 IRR 1.00 (0.88 to 1.13)
a Assessed by responsible physician without any prespecified criteria, assessable ICU days only (discretion of physician) (delirium: experimental n = 421, control
n = 467, atelectasis: n = 258, n = 442, pneumonia: n = 313, n = 388, thrombosis: n = 431, n = 501, decubiti: n = 427, n = 518, contracture: n = 468, n = 558)
Data are presented as n (%)
Definitions: Study days = number of days from study enrolment to ICU discharge including readmissions and weekends where only limited therapy service was
available, session = one single physiotherapy treatment
Abbreviations: IRR = Incidence rate ratio, RD = Risk difference, PT = Physiotherapy, ICU = Intensive care unit
https://doi.org/10.1371/journal.pone.0207428.t004
Early ICU training—RCT
PLOS ONE | https://doi.org/10.1371/journal.pone.0207428 November 14, 2018 11 / 19
of additional endurance training. Early beginning of physiotherapy seems crucial due to early
onset of ICUAW [4]. Accordingly, Schweickert et al [11] combined early mobilisation (within
1.7d of intubation) with daily sedation-interruption leading to reduced delirium and to signifi-
cant functional improvement at hospital discharge. Delirium was equally prevalent in our
groups, though the incidence was comparable to the intervention group of [11] (39 vs 33%).
However, despite the early start, patients in our study achieved the specific mobilisation mile-
stones substantially later [11]. This may also be related to the case mix–our patients were sub-
stantially older and sicker. These patients might not always be suitable for early mobilisation
[40], but could profit from appropriate exercise interventions over the whole ICU stay [12].
However, recent evidence also highlights the impact of pre-ICU health [41, 42] and post-extu-
bation dysphagia [43] on patients’ functional recovery. Our heterogenous sample might there-
fore conceal responsive subgroups. More research is needed whether sicker patients need
longer rehabilitation exposure [44] and for which subgroups recovery will be achievable.
The conducted early endurance training seemed to have unfavourable effects on mobilisation
levels leading to less out-of-bed mobilisations in this group. This self-funded, pragmatic study did
Table 5. Treatment details for the control and experimental groups.
Experimental group (n = 58,
478 study days)
Control group
(n = 57, 558 study days)
p value Group difference
(95% CI)
Physiotherapy (PT)
Total PT visits
(% per study day)
349 (73%) 365 (65%) p = 0.143 IRR 1.12 (0.96 to 1.30)
Total PT sessions
(% per study day)
407 (85%) 377 (68%) p<0.001 IRR 1.26 (1.09 to 1.45)
Two or more sessions per day (% of total PT sessions) 60 (15%) 15 (4%) p<0.001 IRR 3.71 (2.08 to 7.03)
Treatment duration per session (min) a 25.0 (IQR 19.5–27.0) 18.0 (IQR 14.0–21.0) p<0.001 6.00 (4.00 to 8.00)
Time from enrolment to first therapy (days) b 0.16 (IQR 0.07–0.20) 0.16 (IQR 0.07–0.48) p = 0.387 -0.02 (-0.07 to 0.03)
Time from ICU admission to first therapy (days) b 1.95 (IQR 1.41–2.80) 2.15 (IQR 1.53–2.89) p = 0.470 -0.14 (-0.61 to 0.24)
ICU treatment
Length of ICU stay at original hospital (days) 5.9 (IQR 4.0–10.9) 6.1 (IQR 4.6–12.7) p = 0.595 -0.37 (-1.90 to 1.13)
Study days at original hospital 5.0 (IQR 3.0–10.0) 5.0 (IQR 4.0–12.0) p = 0.696 0.00 (-2.00 to 1.00)
Tracheostomies 15 (26%) 15 (26%) p = 0.956 RD 0% (-17% to 16%)
ICU re-admissions 8 (14%) 11 (19%) p = 0.427 RD -5% (-19 to 8%)
Daily energy intake (kcal) over whole ICU stay c 1225±833 1152±867 p = 0.139 MD 73.06 (-23.74 to 169.86)
ICU medication
Study days without sedation 132 (28%) 93 (17%) p<0.001 IRR 1.66 (1.26 to 2.18)
Study days without opiates 41 (9%) 56 (10%) p = 0.477 IRR 0.85 (0.56 to 1.30)
Study days without insulin infusions 289 (61%) 333 (60%) p = 0.872 IRR 1.01 (0.86 to 1.19)
Study days without NMBAs 407 (85%) 468 (84%) p = 0.839 IRR 1.02 (0.89 to 1.16)
Study days without steroids 427 (89%) 422 (76%) p = 0.016 IRR 1.18 (1.03 to 1.35)
Study days without inotropes and vasopressors 191 (40%) 291 (52%) p = 0.005 IRR 0.77 (0.64 to 0.92)
a Median of all patients’ median session duration
b n = 57 for experimental and n = 56 for control group due to two participants death before receiving the allocated intervention
c Excluding oral food intake
Data are presented as median (IQR), mean (SD) or n (%)
Definitions: Visits = days with at least one physiotherapy treatment, study days = number of days from study enrolment to ICU discharge including readmissions and
weekends where only limited therapy service was available, session = one single physiotherapy treatment
Abbreviations: PT = Physiotherapy, ICU = Intensive care unit, NMBAs = Neuromuscular blocking agents, IRR = Incidence rate ratio, RD = Risk difference,
MD = Mean Difference
https://doi.org/10.1371/journal.pone.0207428.t005
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not have additional resources for therapy-delivery. Physiotherapists may therefore have used
available resources for cycling instead of early mobilisation. Although more out-of-bed mobilisa-
tions did not positively impact function of the control group either. The large AVERT trial even
found that early, high-dose out-of-bed mobilisation after stroke enlarges the probability for dis-
ability when compared to low-dose, early mobilisation [45]. Dose-response analyses found the
greatest benefit for short, frequent mobilisations [46]. This would favour the higher frequency of
physiotherapy sessions (11%) in the intervention group, although this percentage might have
been insufficient to reach clinical significance. Similarly, the stepwise approach of our study might
have been too ambitious for the allocated therapy time (7min extra) and cycling insufficiently
dosed (15min versus 30min reported by [47, 48]) to induce musculoskeletal adaptations. How-
ever, the small but significant changes in hemodynamic or oxygen-transport variables appeared to
have been sufficient to stimulate patients to meet the metabolic demands of exercise by adequate
cardiorespiratory adaptations. In contrast, neither passive cycling in deeply sedated patients [49]
nor passive chair transfer [50] increased metabolic costs.
Fig 2. Overview of each physiotherapy intervention for the control and experimental groups. � p<0.003 More than one
therapy intervention per session (= single physiotherapy treatment) possible, total sessions: 407 (85% of study days)
experimental and 377 (68%) control group.
https://doi.org/10.1371/journal.pone.0207428.g002
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Our results are in line with recent studies [13, 15, 37, 38, 51] that failed to show a benefit of
early rehabilitation. Heterogenous populations, difficulties in group separation and exercise
dose may all have contributed. The discrepancy between planned and actual therapy delivery
in these trials implies that the critically ill’s ability to participate in functional exercises may be
overestimated. More attention should be paid to patient fatigue and on whom to target, as very
early muscle preservation might not be feasible in a seriously ill cohort with active catabolic
pathways. Resistance training may therefore be more feasible during recovery.
This study had several limitations. First, blinding of participants and physiotherapists was
impossible. Second, loss of follow-up at 6 months was substantial and unequally distributed
between groups (41% versus 58%) but without any differences in responders and non-
responders. Nevertheless, results from the SF-36 are not adequately powered, possibly attribut-
able to type I error and need to be interpreted with caution. Third, we targeted patients at risk
of ICUAW who were previously independent. Therefore, data from this trial might not be
applicable to patients with previous functional dependency. Fourth, the observed difference of
23m in the 6MWD may be of clinical significance [52], however, to test a difference of 25m
(SD 150) would require at least 1128 participants. Similarly, the two primary outcomes should
be adjusted for multiplicity to avoid type I error.
This study also has several strengths: patients were included very early after ICU admission
and received physiotherapy within 48 hours. Physiotherapy interventions were pragmatic and
reflect real-world resources. The novel use of individually set limits instead of strict target
numbers allows for more rehabilitation flexibility and appears to be a safe approach with a low
incidence of AEs (0.6%). Nevertheless, physiotherapists were experienced in ICU rehabilita-
tion, which is shown in the exceptionally high control group participation. With a total of 1368
edge-of-bed and 1292 out-of-bed mobilisations on 1130 ICU days this trial further underlines
the importance of ICU rehabilitation as a team effort. Additionally, the blinded outcome mea-
surements were patient-centred, valid, reliable and relevant to the devastating consequences of
ICUAW.
In the light of these data future studies should assure sufficiently large sample sizes, aim to
increase exercise-exposure and ensure a targeted, frequent exercise delivery to the right
patient. The effect of early exercise on mental health needs further evaluation, considering that
one in two survivors might experience psychiatric symptoms [53].
Conclusions
We did not find functional benefits of early exercise training over an active usual care rehabili-
tation in mechanically ventilated, critically ill adults. Successively-adapted, early exercise train-
ing seemed to be safe. Early endurance training might improve long-term mental health, but
the most effective rehabilitation intervention to excite neuromuscular adaptations still needs
to be determined.
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